
1. JAMA Netw Open. 2021 Oct 1;4(10):e2129707. doi:
10.1001/jamanetworkopen.2021.29707.

Use of Tumor Necrosis Factor Inhibitors During the COVID-19 Pandemic-Evidence in 
Favor of Monotherapy.

Velloso LA(1).

Author information: 
(1)Department of Internal Medicine, School of Medical Sciences, University of
Campinas, Campinas, SÃ£o Paulo, Brazil.

Comment on
    JAMA Netw Open. 2021 Oct 1;4(10):e2129639.

DOI: 10.1001/jamanetworkopen.2021.29707 
PMID: 34661668  [Indexed for MEDLINE]

